Company intelligence / Profile preview

Huma

London, England, United Kingdomhuma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Huma operates a global digital health platform supporting remote patient monitoring and decentralized clinical trials. Its technology has been adopted by over 4,500 hospitals and clinics across more than 70 countries. The company’s regulated SaMD solutions are used in both care delivery and research settings. Recent clinical results include powering over 800 studies with approximately one million participants; the company reports its platforms can nearly double clinical capacity and reduce readmission rates by more than 30%.

Therapeutic areas: PulmonologyOncologyRare DiseasesOther
Modalities: Device (including regulated Software as a Medical Device)Digital health platform
Industry: Digital Health Medical Devices

Partnerships

AstraZeneca PlcBayer AGHitachi VenturesHat Technology FundEckuity Capital

Beyond the preview

Go deeper on Huma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huma.

Explore the full profile